Patients’ experiences with pre-test genetic counseling provided by breast cancer healthcare professionals: Results from a large prospective multicenter study
The Breast · 2023-06 · 69 · 349-357
DOI: 10.1016/j.breast.2023.03.017 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift The Breast, 2023-06. Verfasst von K Bokkers und 15 weiteren Autor:innen. Beteiligte Einrichtung: Division Laboratories, Pharmacy and Biomedical Genetics, Department of Genetics, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utre…. Hauptthemen laut MEDLINE: Genetic Counseling, Breast Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Pfizer.
Abstract (Originalsprache)
BACKGROUND: Pre-test genetic counseling of patients with breast cancer is increasingly being offered by non-genetic healthcare professionals. We aimed to evaluate the experiences of patients with breast cancer receiving pre-test genetic counseling from a non-genetic healthcare professional (i.e., surgeon or nurse). METHODS: Patients who were diagnosed with breast cancer and received pre-test counseling from their surgeon or nurse (mainstream group), and patients who received pre-test counseling from a clinical geneticist (usual care group) were invited to participate in our multicenter study. Between September 2019 and December 2021, patients received a questionnaire after pre-test counseling (T0) and four weeks after receiving their test results (T1) to evaluate psychosocial outcomes, knowledge, discussed topics and satisfaction. RESULTS: We included 191 patients in our mainstream and 183 patients in our usual care group and received, respectively 159 and 145 follow-up questionnaires. Levels of distress and decisional regret were comparable in both groups. Decisional conflict was higher in our mainstream group (p = 0.01), but only 7% had clinically relevant decisional conflict (vs 2% in usual care group). The possible implications of a genetic test on (secondary) breast or ovarian cancer risks were less frequently discussed in our mainstream group (p = 0.03 and p = 0.000, respectively). In both groups knowledge about genetics was comparable, satisfaction was high and the majority of patients in both groups preferred to give both verbal and written consent for genetic testing. CONCLUSION: Mainstreamed genetic care provides sufficient information for the majority of breast cancer patients to decide about genetic testing with minimal distress.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division Laboratories, Pharmacy and Biomedical Genetics, Department of Genetics, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, the Netherlands.
- Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands; Family Cancer Clinic, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 C…
- Department of Surgery, St. Antonius Hospital, Soestwetering 1, 3543 AZ, Utrecht, the Netherlands.
- Department of Surgery, Diakonessenhuis, Bosboomstraat 1, 3582 KE, Utrecht, the Netherlands.
- Department of Surgery, Gelre Hospitals, Albert Schweitzerlaan 31, 7334 DZ, Apeldoorn, the Netherlands.
- Department of Surgery, St. Jansdal Hospital, Wethouder Jansenlaan 90, 3844 DG, Harderwijk, the Netherlands.
Förderung
- Pfizer
Zitieren
APA
Bokkers, K., Bleiker, E. M. A., Velthuizen, M. E., Koelemij, R., Burgmans, J. P. J., Klinkenbijl, J. H., Schouten van der Velden, A. P., Vermulst, N., Huizinga, B. F., Witkamp, A. J., Frakking, T., Brohet, R. M., Aalfs, C. M., Koole, W., Schoenmaeckers, E. J. P., & Ausems, M. G. E. M. (2023). Patients’ experiences with pre-test genetic counseling provided by breast cancer healthcare professionals: Results from a large prospective multicenter study. The Breast, 69, 349-357. https://doi.org/10.1016/j.breast.2023.03.017
Vancouver
Bokkers K, Bleiker EMA, Velthuizen ME, Koelemij R, Burgmans JPJ, Klinkenbijl JH, et al. Patients’ experiences with pre-test genetic counseling provided by breast cancer healthcare professionals: Results from a large prospective multicenter study. The Breast. 2023;69:349-357. doi:10.1016/j.breast.2023.03.017
BibTeX
@article{Bokkers2023,
author = {Bokkers, K and Bleiker, E M A and Velthuizen, M E and Koelemij, R and Burgmans, J P J and Klinkenbijl, J H and Schouten van der Velden, A P and Vermulst, N and Huizinga, B F and Witkamp, A J and Frakking, T and Brohet, R M and Aalfs, C M and Koole, W and Schoenmaeckers, E J P and Ausems, M G E M},
title = {Patients’ experiences with pre-test genetic counseling provided by breast cancer healthcare professionals: Results from a large prospective multicenter study},
journal = {The Breast},
year = {2023},
volume = {69},
pages = {349--357},
doi = {10.1016/j.breast.2023.03.017}
}
EUVIMED